Skip to main content
. 2022 Aug 30;11(1):1811. doi: 10.4102/ajlm.v11i1.1811

TABLE 2.

Comparison of tuberculosis indicators pre- (2001–2010) and post-introduction (2011–2019) of GeneXpert in three high tuberculosis burden countries in Africa.

Variable Democratic Republic of the Congo
Nigeria
South Africa
Difference p Difference p Difference p
New confirmed pulmonary tuberculosis cases 23 358 0.0002 22 335 0.0011 2125 0.7413
Estimated number of cases 67 667 < 0.0001 92 222 < 0.0001 −42 889 0.5081
Estimated incidence/100k −3.1 0.0067 - - −217 0.1066
New extrapulmonary cases 4994 0.0007 2134 0.0006 −9551 0.1544
Laboratory confirmed RR/MDR-TB - - -
Laboratory confirmed MDR-TB - - -
Tuberculosis case notification numbers 41 726 0.0001 32 348 0.0001 6084 0.8818
Case notification rate/100k 7.8 0.2634 7.6 0.0680 −57.1 0.4901
Tuberculosis case detection rate % 2.7 0.2305 3.3 0.0743 6.2 0.0108
Estimated tuberculosis/HIV % −4.5 0.0190 −3.9 0.1604 −6.6 < 0.0001
Estimated mortality/100k −8.2 0.0264 −6.0 0.0001 −254 < 0.0001
TSR new cases % 9.0 0.0201 8.4 0.0001 9.6 0.0017

Source: World Health Organization (WHO). Global Tuberculosis Programme. In Global TB report [homepage on the Internet]. 2021 [cited 2021 Jun 26]. Available from: https://www.who.int/tb/country/data/download/en/

MDR-TB, multidrug-resistant tuberculosis; TSR, treatment success rate; RR, rifampicin resistant tuberculosis

, No data to enable comparison.